Arthrex is privately held and one of the world's leading orthopedic suppliers.
Arthrex is a privately held global medical device company specializing in orthopedic surgery, sports medicine, and minimally invasive surgical technologies. Founded in 1981 and headquartered in Naples, Florida, the company has grown into one of the leading innovators in the global orthopedics industry with a presence in more than 100 countries. Its business is centered on developing and commercializing products that support the surgical treatment of musculoskeletal conditions — with particular strength in arthroscopic surgery, sports medicine implants, orthobiologics, and surgical enabling technology. A defining feature of Arthrex's business model is its emphasis on surgeon education and training, with a global network of cadaveric and simulation-based training centers that generates surgeon loyalty through knowledge transfer.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Acquisitions and divestitures
• Marketing tactics
• Financial results
• Strengths and weaknesses
• Strategic directions
Table of Contents
1. Executive Summary
2. Company Overview and Business Model
3. Strategic Directions
4. Financial Results
5. SWOT Analysis
6. Technological Know-How and Key Products
7. Acquisitions and Divestitures
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Arthrex — Key Financial Metrics 2023-2025
Table 2. Arthrex — Revenue by Segment 2023-2025
Table 3. Arthrex — Revenue by Geography 2023-2025
Table 4. Arthrex — SWOT Analysis
Table 5. Arthrex — Key Products and Platforms 2025
Table 6. Arthrex — M&A Activity 2020-2025
Table 7. Arthrex — Key Management 2025
Table 8. Arthrex — Strategic Priorities 2025-2030
